CD8A and neoplasm: Interestingly, αvβ3-integrin (discussed in Section 2.3) has been shown to be a regulator of PD-L1, with αvβ3-integrin depleted tumour cells exhibiting reduced PD-L1 expression and increased CD8+ T cell infiltration in vivo.